Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2005
03/17/2005CA2537701A1 One-step reduction and alkylation of proteins
03/17/2005CA2537371A1 Antigenic peptides of rabies virus and uses thereof
03/17/2005CA2537145A1 Co-expression vector for the membrane domains of virus envelope proteins and uses thereof
03/17/2005CA2536793A1 Novel ubp8rp polypeptides and their use in the treatment of psoriasis
03/17/2005CA2536782A1 Recombinant production of antimicrobial agents
03/17/2005CA2536586A1 Modified il-4 mutein receptor antagonists
03/17/2005CA2535734A1 Composition for the prevention/treatment of hbv infections and hbv-mediated diseases
03/17/2005CA2535021A1 Use of insp035 to treat fibrotic disease
03/17/2005CA2534907A1 Homogeneous preparations of il-28 and il-29
03/17/2005CA2525972A1 Methods for identifying inhibitors
03/17/2005CA2517264A1 Ebola peptides and immunogenic compositions containing same
03/16/2005EP1515142A1 Mass spectrometry methods for direct phenotyping of factor XIIIA polymorphisms
03/16/2005EP1514945A1 CD38 as a molecular marker on macrophages for COPD, and as a target molecule for treatment of COPD
03/16/2005EP1514944A1 High-throughput-Assay with high sensitivity for measuring of the activity of beta-adrenergic receptor kinase and for determining the impact of test substances on such activity
03/16/2005EP1514942A1 Method of searching substane having antidiabetic activity
03/16/2005EP1514941A2 Paraquat resistance gene and a vascular tissue- and trichome-specific promotor
03/16/2005EP1514937A1 Production of vaccines
03/16/2005EP1514936A2 A novel method to isolate mutants and to clone the complementing gene
03/16/2005EP1514935A1 Ehd1 gene promoting plant floewering, and utilization thereof
03/16/2005EP1514933A1 Secretory protein or membrane protein
03/16/2005EP1514932A2 Glucagon receptors
03/16/2005EP1514931A1 Immunosuppressant target proteins
03/16/2005EP1514930A1 Novel screening method
03/16/2005EP1514928A1 Method of constructing antibody
03/16/2005EP1514926A1 Inflammatory skin disease-related slurp-2 gene and utilization thereof
03/16/2005EP1514925A1 Method of screening compound affecting amyloid beta production
03/16/2005EP1514922A1 Development of an anionic sensor for living cells: application to the human glycine receptor
03/16/2005EP1514876A2 Antibody against prostate stem cell antigen (PSCA)
03/16/2005EP1514838A1 Process for producing nanoparticle and nanoparticle produced by the process
03/16/2005EP1514557A1 Preventives/remedies for bone and joint diseases
03/16/2005EP1514556A1 Botulinum toxin pharmaceutical compositions
03/16/2005EP1514120A2 Mhc class ii haplotype specific immunodominancy of peptides derived from rsv fusion (f) and attachement (g) proteins
03/16/2005EP1514118A2 Diagnostic and therapeutic use of ras-gtpase-activating sh3-domain-binding protein 2 (g3bp2) for neurodegenerative diseases
03/16/2005EP1514114A2 Method to screen ligands using eukaryotic cell display
03/16/2005EP1514106A1 Targeted therapeutic proteins
03/16/2005EP1514104A1 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species
03/16/2005EP1513959A2 Antiviral inhibitions of capsid proteins
03/16/2005EP1513951A2 Cancer-linked gene as target for chemotherapy
03/16/2005EP1513945A2 Method for universal enzymatic production of bioactive peptides
03/16/2005EP1513936A2 Use of repression blocking sequences in methods for enhancing gene expression
03/16/2005EP1513934A2 Genes and polypeptides relating to human colon cancers
03/16/2005EP1513924A1 Attenuated listeria spp. and methods for using the same
03/16/2005EP1513878A2 Compositions and methods for apo-b48 and apo-b100 assay
03/16/2005EP1513877A1 Marker for stem cells and its use
03/16/2005EP1513876A2 Human 5-ht7 receptor promoter sequence
03/16/2005EP1513875A2 Krib polynucleotides and polypeptides and uses thereof in the treatment of metabolic disorders
03/16/2005EP1513873A2 Therapeutic epitopes and uses thereof
03/16/2005EP1513872A1 INFECTIOUS cDNA OF AN APPROVED VACCINE STRAIN OF MEASLES VIRUS, USE FOR IMMUNOGENIC COMPOSITIONS
03/16/2005EP1513871A2 Pyrrolidinyl peptide nucleic acids
03/16/2005EP1513870A2 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis and methods and products for detecting and/or identifying same
03/16/2005EP1513867A2 Extracellular junctional adhesion molecules
03/16/2005EP1513865A2 Crisp polypeptides as contraceptives and inhibitors of sperm capacitation
03/16/2005EP1513864A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/16/2005EP1513859A2 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis
03/16/2005EP1513853A2 Cardiolipin compositions, methods of preparation and use
03/16/2005EP1513559A1 Increased delivery of a nucleic acid constrtuct in vivo by the poly-l-glutamate (plg) system
03/16/2005EP1513552A1 Packaged virus-like particles for use as adjuvants: method of preparation and use
03/16/2005EP1513549A2 Human prolactin antagonist-angiogenesis inhibitor fusion proteins
03/16/2005EP1513545A2 Methods and means to promote gut absorption
03/16/2005EP1513544A2 Retroyclins: antiviral and antimicrobial peptides
03/16/2005EP1513543A2 Fas peptide mimetics and uses thereof
03/16/2005EP1513542A2 Anti-cancer and wound healing compounds
03/16/2005EP1513415A2 Colour reduction in canola protein isolate
03/16/2005EP1513404A1 Intramyocardial injection of autologous bone marrow
03/16/2005EP1470216A4 Hair follicle growth
03/16/2005EP1465989A4 Growth factor modified protein matrices for tissue engineering
03/16/2005EP1456241B1 Mono-and dual anti-cd4-rantes chemokine/cytokine constructs
03/16/2005EP1438586A4 Fret protease assays for clostridial toxins
03/16/2005EP1414939A4 Seed-preferred regulatory elements and uses thereof
03/16/2005EP1414288A4 Sugar and lipid metabolism regulators in plants iii
03/16/2005EP1343880A4 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates
03/16/2005EP1268784B1 Genes involved in intestinal inflammatory diseases and use thereof
03/16/2005EP1250358B1 Therapeutic peptides
03/16/2005EP1231835A4 Flowering time modification
03/16/2005EP1171143B9 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same
03/16/2005EP1147177A4 Control of virus infection using replication associated proteins, compositions and methods of use
03/16/2005EP1105495B1 Method for producing yeast expressed hpv types 6 and 16 capsid proteins
03/16/2005EP1037923B1 Method for preparing by filtration a virally secure factor viii solution
03/16/2005EP1024826B1 Passive immunization against clostridium difficile disease
03/16/2005EP1003775B1 Hepatitis c inhibitor peptides
03/16/2005EP0918865B1 Immunologically active proteins of borrelia burgdorferi, coded nuclein acids of such and their use in test kits and vaccines
03/16/2005EP0907737B1 Il-6 mutein
03/16/2005EP0861329B1 Dodecahedral adenoviral protein complex, composition containing same and uses thereof
03/16/2005EP0744027B1 Use of methods for identifying hydrophilic signal oligopeptides
03/16/2005CN1596371A Novel self-assembly molecules
03/16/2005CN1596311A Mammalian cell-infecting virus vector encoding epitope-bound beta2m and utilization thereof
03/16/2005CN1596310A Method for producing a recombinant polypeptide
03/16/2005CN1596309A Recombinant DNA encoding the major allergen of plantago lanceolata pollen, PLA L 1, and applications thereof
03/16/2005CN1596304A Protein knobs
03/16/2005CN1596302A Cell culture process
03/16/2005CN1596269A A novel G protein-coupled receptor, gave 10
03/16/2005CN1596268A Chromatographic purification of recombinant human erythropoietin
03/16/2005CN1596267A Genes coding for regulatory proteins
03/16/2005CN1596266A Specific binding agents of human angiopoietin-2
03/16/2005CN1596264A Differentially expressed genes associated with obesity and type 2 diabetes
03/16/2005CN1596130A Genetic remedies for neurodegenerative diseases
03/16/2005CN1594578A Sea anemone neurotoxin gene Sr3 and application thereof
03/16/2005CN1594577A Sea anemone neurotoxin gene Sr4 and application thereof
03/16/2005CN1594576A Sea anemone neurotoxin gene Sr5 and application thereof
03/16/2005CN1594575A Sea anemone neurotoxin gene Sr6 and application thereof
1 ... 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 ... 2916